Jiangsu Hengrui Medicine
600276.SS
$11.91
Share price
0.45%
Change (1 day)
11.71%
Change (1 year)
Categories
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
Jiangsu Hengrui Medicine (600276.SS) - Total liabilities
Total liabilities on the balance sheet as of September 2024 : NZ$0.99 Billion
According to Jiangsu Hengrui Medicine 's latest financial reports the company's total liabilities are NZ$0.99 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Jiangsu Hengrui Medicine - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | NZ$0.61 B | -31.9% |
| 2022-12-31 | NZ$0.90 B | 6.49% |
| 2021-12-31 | NZ$0.84 B | 1.32% |
| 2020-12-31 | NZ$0.83 B | 50.5% |
| 2019-12-31 | NZ$0.55 B | -0.72% |
| 2018-12-31 | NZ$0.56 B | 23.59% |
| 2017-12-31 | NZ$0.45 B | 49.91% |
| 2016-12-31 | NZ$0.30 B | 17.87% |
| 2015-12-31 | NZ$0.25 B | 33.51% |
| 2014-12-31 | NZ$0.19 B | 69.46% |
| 2013-12-31 | NZ$0.11 B | 29.35% |
| 2012-12-31 | NZ$87.73 M | -2.07% |
| 2011-12-31 | NZ$89.59 M | 8.61% |
| 2010-12-31 | NZ$82.48 M | 22.58% |
| 2009-12-31 | NZ$67.29 M | 15.73% |
| 2008-12-31 | NZ$58.14 M | -19.29% |
| 2007-12-31 | NZ$72.05 M | 97.06% |
| 2006-12-31 | NZ$36.56 M | 13.85% |
| 2005-12-31 | NZ$32.11 M | -26.38% |
| 2004-12-31 | NZ$43.62 M | -57.17% |
| 2003-12-31 | NZ$0.10 B | 11.81% |
| 2002-12-31 | NZ$91.09 M | -13.28% |
| 2001-12-31 | NZ$0.10 B |